ontilyv
bial portela & companhia s.a. - opicapon - parkinson krankheit - anti-parkinson-medikamente - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
dacepton 10 mg/ml injektions-/infusionslösung
ever neuro pharma gmbh - apomorphinhydrochlorid - apomorphin
dacepton 10 mg/ml injektionslösung in einer patrone
ever neuro pharma gmbh - apomorphinhydrochlorid hemihydrat -
dacepton 5 mg/ml infusionslösung
ever neuro pharma gmbh - apomorphinhydrochlorid -
apomorphin ever pharma 5 mg/ml infusionslösung
ever neuro pharma gmbh - apomorphinhydrochlorid hemihydrat -
sagilia 1 mg tabletten
medochemie limited (3203620) - rasagilintartrat - tablette - rasagilintartrat (43076) 1,438 milligramm
pramipexol stada 0,088 mg tabletten
stada arzneimittel gmbh - pramipexol dihydrochlorid - pramipexol
pramipexol stada 1,1 mg tabletten
stada arzneimittel gmbh - pramipexol dihydrochlorid - pramipexol
calmolan 0,18 mg - tabletten
g.l. pharma gmbh - pramipexol dihydrochlorid - pramipexol
calmolan 0,35 mg - tabletten
g.l. pharma gmbh - pramipexol dihydrochlorid - pramipexol